| 106.70 Delayed Data As of 9:30am ET |  -0.10 / -0.09%Today’s Change | 96.00 Today|||52-Week Range 115.70 | +4.52% Year-to-Date |
| How to Invest in Cancer-Fighting Stocks 4:00pm / MotleyFool.com - Paid Partner Content |
| Previous close | 106.80 |
| Today’s open | 106.70 |
| Day’s range | 106.70 - 106.70 |
| Volume | 73 |
| Average volume (3 months) | 1,496 |
| Market cap | $13.4B |
| Earnings growth (last year) | -84.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1.24% |
| P/E ratio | 17.3 |
| Price/Sales | 2.56 |
| Price/Book | 2.30 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $17.5B |
| Annual profit (last year) | $460.1M |
| Net profit margin | 7.37% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman-Executive Board & CEO Stefan Oschmann |
Chief Financial Officer Marcus Kuhnert |
Corporate headquarters Darmstadt, Hessen |
